Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
01/18/2012
Trade Name:
Viread
Generic or Proper Name (*):
tenofovir disoproxil fumarate
Indications Studied:
Treatment of HIV infection in combination with other antiretroviral agents
Therapeutic Category:
Antiviral
Ages Studied:
2 - <12 years
Study #:
2
Study Type:
Safety/Pharmacokinetic
Study Design:
Open Label/Traditional Pharmacokinetic
No Patients:
32
No Centers:
1
No Countries:
1
BPCA(B), PREA(P):
B,P
White:
26
Native Hawaiian or Pacific Islander:
1
-
-